Lyme disease infection causes long-term changes in immune cells

A new study led by researchers at Tufts University School of Medicine suggests that infection with Borrelia burgdorferithe bacteria that causes Lyme disease, can cause lasting changes to the immune system, even after the infection is treated. The changes occur in the bone marrow, where many of the body’s immune cells are made, potentially changing how the immune system responds to future threats.

The results, published in iScienceoffer new clues about how an infection might have effects that persist after the bacteria is gone. The researchers say this work could ultimately help identify biological markers associated with prolonged symptoms after Lyme disease and identify potential therapeutic targets.

A lifetime of infections and inflammatory exposures creates small editing marks, called epigenetic changes, in the immune system’s record of everything it has encountered so far. Our study revealed that epigenetic changes in bone marrow imprinted by Borrelia burgdorferi infection can essentially revise the “biography” of the immune system and how it responds over time. »

Tanja Petnicki-Ocwieja, lead study author and research assistant professor of molecular biology and microbiology, School of Medicine, Tufts University

To study the long-term effects of Lyme disease, researchers used a mouse model to examine bone marrow cells after infection, including in mice that then received antibiotics. They found that Borrelia burgdorferi the infection produced distinct epigenetic changes – chemical modifications that can influence which genes are turned on or off – in bone marrow cells.

The effects were particularly apparent in macrophages, immune cells produced in the bone marrow that serve as first responders to infection. Macrophages detect potential threats, surround invading microbes, and release chemical signals that call other immune cells to attack the invaders.

Macrophages produced by mice previously exposed to Borrelia burgdorferi showed suppressed expression of genes involved in this inflammatory response for at least 15 weeks after infection.

“When macrophages first encounter Borrelia burgdorferithey sound the alarm and tell other immune cells to come and destroy the bacteria,” Petnicki-Ocwieja said. “But once these epigenetic changes are imprinted in the bone marrow, the macrophages seem to emit fewer of these alarms.”

Notably, an altered immune response was also observed in mice given antibiotics, suggesting that some changes may occur relatively early in the course of infection and do not require prolonged or ongoing bacterial disease.

“This suggests that an individual’s first exposure to Borrelia burgdorferi is sufficient to cause long-term effects on the immune response,” said Yuelin Zhong, a doctoral student in immunology at the Graduate School of Biomedical Sciences and first author of the study.

The findings do not establish that these immune changes occur in people with Lyme disease or that they cause persistent symptoms. To determine whether these changes are relevant to human disease, researchers next want to examine epigenetic markers in people infected with Lyme disease.

Petnicki-Ocwieja will collaborate with co-author Linden Hu, the Paul and Elaine Chervinsky Professor of Immunology at the School of Medicine, to analyze immune cells circulating in the blood from a large multi-institutional study led by Tufts that follows patients for up to 15 months after a Lyme disease diagnosis.

The researchers hope this work will help determine whether people who develop prolonged symptoms have different epigenetic patterns than those who recover without persistent symptoms.

“My hope is to sequence these epigenetic marks to create profiles of the effect of Lyme disease on an individual’s immune system,” Petnicki-Ocwieja said. “We can then use this to see if the profiles belonging to patients with long-term symptoms are different from those of patients who have successfully recovered.”

If such differences are found, they could provide clues as to why some people continue to experience symptoms after treatment for Lyme disease and potentially help researchers identify biomarkers of prolonged illness or new ways to treat that persistent fatigue, joint pain or cognitive difficulties.

Source:

Journal reference:

Zhong, Y., and others. (2026). Borrelia burgdorferi infection induces a characteristic reprogramming of bone marrow cells. iScience. DOI: 10.1016/j.isci.2026.118281. https://www.cell.com/iscience/fulltext/S2589-0042(26)03664-3

Gn Health

Logo